Supportive Therapien

PD Dr. Kähler

  • Riaz F et al. The adoption of immune checkpoint inhibitors and patterns of care at the end of life.
  • Krishnan M et al. Impact of performance status on response and survival among patients receiving checkpoint inhibitors for advanced solid tumors.
  • Landre T et al. Is there a benefit of immune checkpoint inhibitors for patients over 75 years of age with advanced cancer in first and second line setting: A meta-analysis.
  • Budhathoki N et al. Impact of immune checkpoint and BRAF inhibitors on the incidence of second primary malignancies (SPM) in melanoma.
 

PD Dr. Schuler

  • Edge S et al. Value of oncologist generated “surprise question” in predicting survival in metastatic cancer.
  • Manz C et al. Effect of integrating machine learning mortality estimates with behavioral nudges to increase serious illness conversions among patients with cancer: A stepped-wedge cluster randomized trial.
  • Al-Rashdan A et al. Predictive survival ability of patient-reported in comparison to physician-reported performance status in solid malignancies.
  • Yeong-Fung Sheng I et al. Thromboembolism (TE) in patients (pts) with bladder cancer treated with checkpoint inhibitors (CPIs).
 

PD Dr. Würstlein

  • Richardson D et al. The effect of neutropenia on patient-reported functioning and quality of life (QOL) among palbociclib participants of the MADELINE study.
  • Clemons M et al. A multicenter study comparing granulocyte-colony stimulating factors to antibiotics for primary prophylaxis of taxotere/cyclophosphamide-induced febrile neutropenia in patients with early-stage breast cancer.
  • Khoury K et al. Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function.
  • Sohal M et al. Using digital engagement to proactively manage symptoms in patients on capecitabine.

Supportive Therapien Highlight

404 Not Found

Die Seite wurde leider nicht gefunden

Gründe dafür könnten sein, dass Sie eine falsche oder veraltete URL aufgerufen haben. Oder aber die Seite wurde von uns umbenannt, verschoben und archiviert. Versuchen Sie es noch einmal und aktualisieren Sie die Seite.

Andernfalls verwenden Sie bitte den folgenden Link, um die von Ihnen gewünschten Inhalte zu finden

Zur Startseite